From research to reality: molecular biomarkers in immuno-oncology – Bristol-Myers Squibb sponsored session
Programme stream(s): Treatment
Speaker: John Gosney, Royal Liverpool University Hospital, UK
Speaker: Mike Hubank, The Royal Marsden, UK
Date and time: Mon 05-Nov-2018, 1:00 pm-2:00 pm
The field of Immuno-Oncology (I-O) has expanded rapidly and now encompasses a range of agents often combined with different treatment modalities across different tumours. However, whilst survival outcomes have improved overall, a significant proportion of patients respond poorly to I-O therapy. Unravelling the inherent biological complexity of the tumour and immune system is crucial to understanding how to improve outcomes for these patients. This includes the identification of biomarkers to select patients for therapy, helping clinicians to optimally employ precision medicine and choose the right treatment for the right patient at the right time.
At this symposium, chaired by Professor Gary Middleton (University of Birmingham), we will consider what the future holds for I-O molecular biomarker research and the practical implications for the NHS as the UK undergoes a genomics transformation. In the first presentation, Professor John Gosney (Royal Liverpool University Hospital) will review biomarkers under current evaluation and the key learnings from those now embedded in clinical practice. In the second presentation, Dr Mike Hubank (The Royal Marsden) will discuss the technical, regulatory and logistical challenges associated with transitioning a novel biomarker into routine diagnostic use.
We hope you will join us for this informative event.
13:00 – 13:15 Precision medicine in I-O: The value of predictive profiling, Gary Middleton
13:15 – 13:30 From research to results: Managing the biomarker evolution in lung cancer, John Gosney
13:30 – 13:45 From bench to bedside: Transitioning a new biomarker into routine practice, Mike Hubank
13:45 – 14:00 Panel Discussion, Gary Middleton and Faculty Panel
14:00 Meeting Close
For healthcare professionals and scientific researchers only.